Home | About | Journals | Submit | Contact Us | Français |

**|**BMC Biochem**|**v.12; 2011**|**PMC3195097

Formats

Article sections

Authors

Related links

BMC Biochem. 2011; 12: 53.

Published online 2011 September 26. doi: 10.1186/1471-2091-12-53

PMCID: PMC3195097

Feng Qi: gro.mahnrubdrofnas@iqf; Ranjan K Pradhan: ude.wcm@nahdarpr; Ranjan K Dash: ude.wcm@hsadr; Daniel A Beard: moc.liamg@addraeb

Received 2011 June 7; Accepted 2011 September 26.

Copyright ©2011 Qi et al; licensee BioMed Central Ltd.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

This article has been cited by other articles in PMC.

Mitochondrial 2-oxoglutarate (α-ketoglutarate) dehydrogenase complex (OGDHC), a key regulatory point of tricarboxylic acid (TCA) cycle, plays vital roles in multiple pathways of energy metabolism and biosynthesis. The catalytic mechanism and allosteric regulation of this large enzyme complex are not fully understood. Here computer simulation is used to test possible catalytic mechanisms and mechanisms of allosteric regulation of the enzyme by nucleotides (ATP, ADP), pH, and metal ion cofactors (Ca^{2+ }and Mg^{2+}).

A model was developed based on an ordered ter-ter enzyme kinetic mechanism combined with con-formational changes that involve rotation of one lipoic acid between three catalytic sites inside the enzyme complex. The model was parameterized using a large number of kinetic data sets on the activity of OGDHC, and validated by comparison of model predictions to independent data.

The developed model suggests a hybrid rapid-equilibrium ping-pong random mechanism for the kinetics of OGDHC, consistent with previously reported mechanisms, and accurately describes the experimentally observed regulatory effects of cofactors on the OGDHC activity. This analysis provides a single consistent theoretical explanation for a number of apparently contradictory results on the roles of phosphorylation potential, NAD (H) oxidation-reduction state ratio, as well as the regulatory effects of metal ions on ODGHC function.

The 2-oxoglutarate (α-ketoglutarate; αKG) dehydrogenase complex (OGDHC, EC 1.2.4.2, EC 2.3.1.61, and EC 1.6.4.3) is a multi-enzyme complex which catalyzes the chemical reaction:

$$\begin{array}{c}\alpha \mathsf{\text{K}}{\mathsf{\text{G}}}^{\mathsf{\text{2-}}}\mathsf{\text{+CoAS}}{\mathsf{\text{H}}}^{4-}\mathsf{\text{+NA}}{\mathsf{\text{D}}}^{-}+{\mathsf{\text{H}}}_{\mathsf{\text{2}}}\mathsf{\text{O}}& \mathsf{\text{Succinyl-Co}}{\mathsf{\text{A}}}^{4-}{\mathsf{\text{+CO}}}_{\mathsf{\text{3}}}^{\mathsf{\text{2}}-}\mathsf{\text{+NAD}}{\mathsf{\text{H}}}^{\mathsf{\text{2}}-}\mathsf{\text{+}}{\mathsf{\text{H}}}^{\mathsf{\text{+}}}\\ \end{array}$$

(1)

OGDHC is primarily located within the mitochondrial matrix and is a key regulatory enzyme complex in the TCA cycle, responsible for oxidative decarboxylation of 2-oxoglutarate, transferring a succinyl group to coenzyme A (CoASH^{4-}) and producing reducing equivalents (NADH^{2-}) for the electron transport system. Regulation of OGDHC not only affects the distribution of 2-oxoglutarate between the TCA cycle and malate-aspartate shuttle system, but also has effects on the oxidative deamination of glutamate. OGDHC is a crucial target of reactive oxygen species (ROS) and also able to generate ROS, which make it distinctly important for bioenergetics [1]. The molecular organization of OGDHC is similar to that of the pyruvate dehydrogenase complex (PDHC) as it belongs to the same heterogeneous family of 2-oxo acid dehydrogenase multi-enzyme complexes [2]. It consists of multiple copies of three enzyme components: oxoglutarate dehydrogenase (E1), dihydro-lipoamide succinyltransferase (E2), and dihydro-lipoamide dehydrogenase (E3). Consecutive actions of these enzymes catalyze the oxidation of 2-oxoglutarate and reduction ofNAD^{-}, which results in the production of NADH^{2- }and Succinyl-CoA^{4- }(Figure (Figure1A).1A). Allosteric interactions associated with the E1 component are known to be the predominant target for controlling of OG-DHC activity [3].

OGDHC was first purified from the pig heart mitochondria by Sanadi *et al*. [4] and subsequently studied by many researchers to examine its catalytic and regulatory properties within permeabilized, un-coupled, and coupled mitochondria from a variety of mammalian tissues [5-11]. A catalytic mechanism for the overall reaction of the enzyme complex was also first proposed by Sanadi *et al*. [4] which suggested that the coenzyme, NAD^{-}, and 2-oxoglutaric acid participate in the reaction with the help of the cofactors thiamine pyrophosphate (TPP), lipoic acid, and FAD^{2- }[12,13]. Their proposed mechanism is a Hexa-Uni-Ping-Pong mechanism in Cleland's terminology [14] where it is assumed that the first product (CO_{2}) is released before the second substrate (CoASH^{4-}) binds, and the second product (Succinyl-CoA^{4-}) is released before the third substrate (NAD^{-}) binds to the enzyme. Subsequently, Koike *et al*. [15] postulated another mechanism in which, the lipoic acids transfer intermediates by rotating between the three catalytic sites. Furthermore, experimental results of fluorescence resonance energy transfer and dynamic anisotropy showed that the lipoic acids in the E2 component undergo motion where they rotate between different catalytic sites [16-18]. The results of steady-state kinetic studies done by Hamada *et al*. [19] and Smith *et al*. [10] contradict each other, and not all results are compatible with the Sanadi mechanism [4]. This issue was addressed by Mcminn and Ottaway [20] with kinetic studies based on the Fromm method [21]. Mcminn and Ottaway [20] explained the observed nonlinearity in the reciprocal plots of the results and proposed a phenomenological mechanism with semi-random characteristic. A recent study by Aevarsson *et al*. [22] on the crystal structure and architecture of 2-oxo acid dehydrogenase multi-enzyme complexes, provides interesting insights into the plausible kinetic mechanism of 2-oxo acid dehydrogenase family which includes OGDHC.

It has been consistently shown that the activity of OGDHC is controlled by various factors, including the variations of the NAD oxidation-reduction state, the state of phosphorylation of the nucleotide systems, and the ratio of succinyl-CoA to CoA-SH. Regulation by reversible phosphorylation has not been demonstrated. Experiments in isolated mitochondria of heart, liver, and kidney have shown that the OGDHC is regulated by Ca^{2+ }ions with a marked decrease in the apparent *K _{m }*for 2-oxoglutarate in the presence of adenine nucleotides and minimal effect of Ca

Although a number of attempts have been made to understand the catalytic mechanisms of OGDHC, both experimentally and theoretically, there is no mechanistic model that consistently explains the available experimental data on the kinetics of this enzyme complex and adequately describes the regulatory roles of nucleotides and other metal ion cofactors (Ca^{2+}, Mg^{2+}, etc.). Therefore a mechanistic model of OGDHC is needed to understand the orchestrated controlling of OGDHC by cofactors inside mitochondria under different physiological conditions. In the present work, a kinetic model of OGDHC is introduced to quantitatively understand the catalytic properties and regulation of OGDHC, based on the observations from a large number of independent experimental studies in mammalian tissues. The model accurately describes the catalytic properties of this enzyme complex observed experimentally, and clarifies many contradictory results reported in earlier studies.

In this section, we first present a general kinetic model for conformational changes in OGDHC, based on a presumed ter-ter enzyme mechanism via substrate channeling. The model is then used to characterize the kinetics of the 2-oxoglutarate dehydrogenase reaction (Equation 1) and further extended to describe the regulatory roles of cofactors, i.e., nucleotides and various metal ions. The kinetic parameters of the model are estimated using a wide variety of experimental data, available in the literature.

The kinetic equation of the proposed model for OGDHC reaction is derived from a ter-ter enzyme me-chanism combined with a model of conformational changes that represent the rotation of the single lipoic acid between different catalytic sites [15,18]. The derivation is inspired by a previously developed model for trans-carboxylase [31]. The assumption of the model is that the enzyme complex is composed of three sub-enzyme (E1, E2, and E3), each with one binding site: site 1 binds to 2-oxoglutarate (*α*KG^{2-}) or corresponding product CO_{2}, site 2 binds to CoASH^{4- }or corresponding product Succinyl-CoA^{4-}, site 3 binds toNAD^{- }or corresponding product NADH^{2- }(Figure (Figure1A).1A). Furthermore, the basic mechanism involves conformational changes, where the rotation of one lipoic acid between three catalytic sites leads to transfer of succinyl from E1 to E2 and proton from E2 to E3. In the catalytic cycle, the disulfide at the tip of the lipoyl can be in oxidized, reduced or semi-reduced li-poate forms, the semi-reduced form is bound with succinyl residue transferred from 2-oxoglutarate (Figure (Figure1B1B).

Each of the six conformational states shown in Figure Figure1B1B can involve any possible binding states associated with the enzyme. For example, the first site is either empty or bound to 2-oxoglutarate or CO_{2}; the second site is either empty or bound to CoASH^{4- }or Succinyl-CoA^{4-}; and the third site is either empty or bound to NAD^{- }or NADH^{2-}. Therefore, there are a total of 27 binding states for each one of the six conformational states, which gives rise to 27 × 6 = 162 distinct states in the model. Here we denote these 162 states as ${E}_{xyz}^{i}$, where *i * {1, 2, 3, 4, 5, 6} represents the index for conformational states, and *x * {Ø, A, P}, *y * {Ø, B, Q} and *z * {Ø, C, R} represent the binding states of site 1, site 2, and site 3. The lower-case ${e}_{xyz}^{i}$ is used to represent the fraction of each state. Therefore, the total fractional states can be expressed as

$${e}_{total}^{i}=\sum _{x\{\mathrm{,\mathsf{\text{A,P}}}\},y\{\mathrm{,\mathsf{\text{B,Q}}}\},z\{\mathrm{,\mathsf{\text{C,R}}}\}{e}_{xyz}^{i}.}$$

(2)

We assume rapid equilibrium binding for all 27 binding states, implying that the binding processes are much faster than the conformational change processes. With this assumption, Equation (2) can be written as:

$$\begin{array}{ccc}\hfill {e}_{total}^{i}& ={e}_{free}^{i}\times \left(1+\left[\mathsf{\text{A}}\right]/{K}_{A}+\left[\mathsf{\text{P}}\right]/{K}_{P}\right)\hfill & \hfill \\ \hfill & \times \left(1+\left[\mathsf{\text{B}}\right]/{K}_{B}+\left[\mathsf{\text{Q}}\right]/{K}_{Q}\right)\hfill \\ \hfill & \times \left(1+\left[\mathsf{\text{C}}\right]/{K}_{C}+\left[\mathsf{\text{R}}\right]/{K}_{R}\right),\hfill \\ \hfill \end{array}$$

(3)

where ${e}_{free}^{i}{e}_{i}^{}$ denotes the fraction of free enzyme complex that binds to the reactants; *K _{A}, K_{B}, K_{C}, K_{P}, K_{Q }*and

We define *f _{i }*as the fractions in conformation state

$$\begin{array}{c}{f}_{1}=\left(\frac{\left[\mathsf{\text{A}}\right]/{K}_{A}}{1+\left[\mathsf{\text{A}}\right]/{K}_{A}+\left[\mathsf{\text{P}}\right]/{K}_{P}}\right),\\ {f}_{\mathsf{\text{-1}}}=\left(\frac{\left[\mathsf{\text{P}}\right]/{K}_{P}}{1+\left[\mathsf{\text{A}}\right]/{K}_{A}+\left[\mathsf{\text{P}}\right]/{K}_{P}}\right),\\ {f}_{3}=\left(\frac{\left[\mathsf{\text{B}}\right]/{K}_{B}}{1+\left[\mathsf{\text{B}}\right]/{K}_{B}+\left[\mathsf{\text{Q}}\right]/{K}_{Q}}\right),\\ {f}_{\mathsf{\text{-3}}}=\left(\frac{\left[\mathsf{\text{Q}}\right]/{K}_{Q}}{1+\left[\mathsf{\text{B}}\right]/{K}_{B}+\left[\mathsf{\text{Q}}\right]/{K}_{Q}}\right),\\ {f}_{5}=\left(\frac{\left[\mathsf{\text{C}}\right]/{K}_{C}}{1+\left[\mathsf{\text{C}}\right]/{K}_{C}+\left[\mathsf{\text{R}}\right]/{K}_{R}}\right),\\ {f}_{\mathsf{\text{-5}}}=\left(\frac{\left[\mathsf{\text{R}}\right]/{K}_{R}}{1+\left[\mathsf{\text{C}}\right]/{K}_{C}+\left[\mathsf{\text{R}}\right]/{K}_{R}}\right).\\ \end{array}$$

(4)

The net turn-over (reaction velocity) for this mechanism can be expressed

$$v=\frac{V}{\left[{E}_{total}\right]}={f}_{5}{k}_{5}\left[{e}_{total}^{5}\right]-{f}_{-5}{k}_{-5}\left[{e}_{total}^{6}\right].$$

(5)

Applying the King and Altman method to the scheme shown in Figure Figure1B1B gives the following expression for the net reaction velocity:

$$v=\frac{{f}_{1}{f}_{3}{f}_{5}{k}_{1}{k}_{2}{k}_{3}{k}_{4}{k}_{5}{k}_{6}-{f}_{-1}{f}_{-3}{f}_{-5}{k}_{-1}{k}_{-2}{k}_{-3}{k}_{-4}{k}_{-5}{k}_{-6}}{\left(\begin{array}{c}{f}_{-1}{f}_{-3}{k}_{-1}{k}_{-2}{k}_{-3}{k}_{-4}\left({k}_{6}+{k}_{-6}\right)+{f}_{-1}{f}_{5}{k}_{-1}{k}_{-2}{k}_{4}{k}_{5}\left({k}_{6}+{k}_{-6}\right)\\ +{f}_{3}{f}_{5}{k}_{2}{k}_{3}{k}_{4}{k}_{5}\left({k}_{6}+{k}_{-6}\right)+{f}_{-3}{f}_{-5}\left({k}_{2}+{k}_{-2}\right){k}_{-3}{k}_{-4}{k}_{-5}{k}_{-6}\\ +{f}_{-3}{f}_{1}\left({k}_{2}+{k}_{-2}\right){k}_{-3}{k}_{-4}{k}_{1}{k}_{6}+{f}_{1}{f}_{5}\left({k}_{2}+{k}_{-2}\right){k}_{1}{k}_{4}{k}_{5}{k}_{6}\\ +{f}_{1}{f}_{3}\left({k}_{4}+{k}_{-4}\right){k}_{1}{k}_{2}{k}_{3}{k}_{6}+{f}_{-1}{f}_{-5}\left({k}_{4}+{k}_{-4}\right){k}_{-5}{k}_{-6}{k}_{-1}{k}_{-2}\\ +{f}_{3}{f}_{-5}\left({k}_{4}+{k}_{-4}\right){k}_{-5}{k}_{-6}{k}_{2}{k}_{3}+{f}_{-1}{f}_{-3}{f}_{5}{k}_{-1}{k}_{-3}{k}_{5}{k}_{-2}\left({k}_{6}+{k}_{-6}\right)\\ +{f}_{-1}{f}_{3}{f}_{5}{k}_{-1}{k}_{3}{k}_{5}{k}_{4}\left({k}_{6}+{k}_{-6}\right)+{f}_{-3}{f}_{-5}{f}_{1}{k}_{-3}{k}_{-5}{k}_{1}{k}_{-4}\left({k}_{2}+{k}_{-2}\right)\\ +{f}_{-3}{f}_{1}{f}_{5}{k}_{-3}{k}_{1}{k}_{5}{k}_{6}\left({k}_{2}+{k}_{-2}\right)+{f}_{-1}{f}_{-5}{f}_{3}{k}_{-1}{k}_{-5}{k}_{3}{k}_{-6}\left({k}_{-4}+{k}_{4}\right)\\ +{f}_{-5}{f}_{1}{f}_{3}{k}_{-5}{k}_{1}{k}_{3}{k}_{2}\left({k}_{4}+{k}_{-4}\right)+{f}_{1}{f}_{3}{f}_{5}{k}_{1}{k}_{3}{k}_{5}\left({k}_{4}{k}_{2}+{k}_{6}{k}_{4}+{k}_{2}{k}_{6}\right)\\ +{f}_{-1}{f}_{-3}{f}_{-5}{k}_{-1}{k}_{-3}{k}_{-5}\left({k}_{-2}{k}_{-4}+{k}_{-4}{k}_{-6}+{k}_{-6}{k}_{-2}\right)\\ \end{array}\right)}.$$

(6)

This complex expression can also be obtained using our KAPattern package [32], available freely for the derivation of enzyme rate equations. Substituting the fractional occupancy distributions as defined in Equation (4), we obtain an expression for the reaction velocity in terms of the individual rate constants and dissociation constants. The kinetic constants can be also expressed in terms of various rate constants. Using the Haldane relationship, the velocity equation can be written as:

$$v=\frac{{V}_{f}{V}_{r}\left([\text{A][B][C}]-[\text{P][Q][R}]/{K}_{eq}\right)}{\left(\begin{array}{l}{V}_{r}[\text{A][B][C}]+{K}_{mC}{V}_{r}[\text{A][B][R}]/{K}_{ir}\\ +{K}_{mC}{V}_{r}[\text{A][B]+}{K}_{mB}{V}_{r}[\text{A][C][Q}]/{K}_{iq}\\ +{K}_{mB}{V}_{r}[\text{A][C}]+{K}_{mP}{V}_{f}[\text{A][Q][R}]/{K}_{ia}/{K}_{eq}\\ +{K}_{ic}{K}_{mB}{V}_{r}[\text{A][Q]/}{K}_{iq}\text{+}{K}_{mA}{V}_{r}[\text{B][C][P}]/{K}_{ip}\\ +{K}_{mA}{V}_{r}\text{[B][C}]+{K}_{ia}{K}_{mC}{V}_{r}[\text{B][P][R}]/{K}_{ip}/{K}_{ir}\\ +{K}_{ia}{K}_{mC}{V}_{r}\text{[B][R}]/{K}_{ir}+{K}_{ib}{K}_{mA}{V}_{r}[\text{C][P][Q}]/{K}_{iq}/{K}_{ip}\\ +{K}_{ib}{K}_{mA}{V}_{r}[\text{C][P]/}{K}_{ip}\text{+}{V}_{f}\text{[P][Q][R}]/{K}_{eq}\\ +{K}_{mR}{V}_{f}[\text{P][Q]/}{K}_{eq}\text{+}{K}_{mQ}{V}_{f}[\text{P][R}]/{K}_{eq}+{K}_{mP}{V}_{f}\text{[Q][R}]/{K}_{eq}\end{array}\right)},$$

(7)

where the kinetic constants are defined as:

$$\begin{array}{c}{V}_{f}=nu{m}_{1}/Coe{f}_{ABC},\phantom{\rule{0.3em}{0ex}}{V}_{r}=nu{m}_{2}/Coe{f}_{PQR},\phantom{\rule{0.3em}{0ex}}{K}_{mA}=Coe{f}_{BC}/Coe{f}_{ABC},\phantom{\rule{0.3em}{0ex}}{K}_{mB}=Coe{f}_{AC}/Coe{f}_{ABC},\\ {K}_{mC}=Coe{f}_{AB}/Coe{f}_{ABC},\phantom{\rule{0.3em}{0ex}}{K}_{mP}=Coe{f}_{QR}/Coe{f}_{PQR},\phantom{\rule{0.3em}{0ex}}{K}_{mQ}=Coe{f}_{PR}/Coe{f}_{PQR},\phantom{\rule{0.3em}{0ex}}{K}_{mR}=Coe{f}_{PQ}/Coe{f}_{PQR},\\ {K}_{ip}=Coe{f}_{BR}/Coe{f}_{BPR}=Coe{f}_{BC}/Coe{f}_{BCP},\phantom{\rule{0.3em}{0ex}}{K}_{iq}=Coe{f}_{CP}/Coe{f}_{CPQ}=Coe{f}_{AC}/Coe{f}_{ACQ},\\ {K}_{ir}=Coe{f}_{AQ}/Coe{f}_{AQR}=Coe{f}_{AB}/Coe{f}_{ABR},\phantom{\rule{0.3em}{0ex}}{K}_{ia}=Coe{f}_{QR}/Coe{f}_{AQR}=Coe{f}_{BR}/Coe{f}_{ABR},\\ {K}_{ib}=Coe{f}_{PR}/Coe{f}_{BPR}=Coe{f}_{CP}/Coe{f}_{BCP},\phantom{\rule{0.3em}{0ex}}{K}_{ic}=Coe{f}_{PQ}/Coe{f}_{CPQ}=Coe{f}_{AQ}/Coe{f}_{ACQ}\phantom{\rule{0.3em}{0ex}}\mathsf{\text{and}}\phantom{\rule{0.3em}{0ex}}\\ {K}_{eq}=nu{m}_{1}/nu{m}_{2}.\\ \end{array}$$

Here we used the shorthand notation similar to that of Segel [33] where *num *= *k*_{1 }*k*_{2 }*k*_{3 }*k*_{4 }*k*_{5 }*k _{6}K_{P}K_{Q}K_{R}, num *=

In the ter-ter biochemical reaction, the fourteen unknown kinetic parameters in Equation (7) are related to the equilibrium constant *K _{eq }*(known) via the following equilibrium relationship:

$$\begin{array}{ccc}\hfill {K}_{eq}& ={\left(\frac{\mathsf{\text{[P][Q][R]}}}{\mathsf{\text{[A][B][C]}}}\right)}_{\mathsf{\text{eq}}}=\frac{nu{m}_{1}}{nu{m}_{2}}\hfill & \hfill \\ \hfill & =\frac{{K}_{ip}{K}_{iq}{K}_{ir}}{{K}_{ia}{K}_{ib}{K}_{ic}}=\frac{{V}_{f}{K}_{mP}{K}_{iq}{K}_{ir}}{{V}_{r}{K}_{ia}{K}_{mB}{K}_{ic}}\hfill \\ \hfill & =\frac{{V}_{f}{K}_{ip}{K}_{mQ}{K}_{ir}}{{V}_{r}{K}_{ia}{K}_{ib}{K}_{mC}}=\frac{{V}_{f}{K}_{ip}{K}_{iq}{K}_{mR}}{{V}_{r}{K}_{mA}{K}_{ib}{K}_{ic}},\hfill \\ \hfill \end{array}$$

(8)

reducing the total number of independent unknown kinetic parameter to thirteen.

We apply the above general form of the ter-ter enzyme mechanism for the analysis of available expe-rimental data on the kinetic of OGDHC to estimate the unknown kinetic parameters and to elucidate whether the proposed mechanism is able to explain the available kinetic data.

In the TCA cycle, OGDHC is primarily involved in the fifth step for oxidation of acetyl-CoA. The reference chemical reaction is given by Equation (1). The corresponding biochemical reaction is given by

$$\begin{array}{c}\alpha \mathsf{\text{KG+CoASH}}\\ \mathsf{\text{+NAD}}\mathrm{\mathsf{\text{succinyl}}-\phantom{\rule{0.3em}{0ex}}{\mathsf{\text{CoA+CO}}}_{\mathsf{\text{2,tot}}}^{}\mathsf{\text{+NADH}}\mathsf{\text{.}}}& \end{array}$$

(9)

Here biochemical reactants, such as *α*KG, correspond to ensemble chemical species, such as *α*KG^{2-}, H *α*KG^{-}, etc. The chemical reaction in Equation (1) is unambiguously balanced in terms of mass and charge, whereas this biochemical reaction is not. In this reaction, the reactant CO_{2, tot }represents the sum of aqueous carbon dioxide and bicarbonate species (${\mathsf{\text{CO}}}_{3}^{\mathsf{\text{2}}-}$, ${\mathsf{\text{HCO}}}_{\mathsf{\text{3}}}^{-}$ and H_{2}CO_{3}).

The equilibrium constant for the reference reaction can be written as:

$$\begin{array}{ccc}\hfill {K}_{eq,ogdhc}^{0}& ={\left(\frac{\mathsf{\text{[Succinyl-Co}}{\mathsf{\text{A}}}^{4-}{\mathsf{\text{][CO}}}_{\mathsf{\text{3}}}^{\mathsf{\text{2}}-}\mathsf{\text{][NAD}}{\mathsf{\text{H}}}^{\mathsf{\text{2}}-}\mathsf{\text{][}}{\mathsf{\text{H}}}^{\mathsf{\text{+}}}\mathsf{\text{]}}}{\mathsf{\text{[}}\alpha \mathsf{\text{K}}{\mathsf{\text{G}}}^{\mathsf{\text{2-}}}\mathsf{\text{][CoAS}}{\mathsf{\text{H}}}^{4-}\mathsf{\text{][NA}}{\mathsf{\text{D}}}^{-}\mathsf{\text{]}}}\right)}_{eq}\hfill & \hfill \\ \hfill & =exp\left(-\frac{{\Delta}_{r}{G}_{ogdhc}^{0}}{RT}\right),\hfill \\ \hfill \end{array}$$

(10)

where ${\Delta}_{r}{G}_{ogdhc}^{0}$ is the standard Gibbs free energy of the reference reaction which is computed using the basic thermodynamic data (298.15 K, I = 0.15 M) listed in Li *et al*. [34].

For the development of the kinetic model of OGDHC, we assume that the ter-ter enzyme mechanism proposed in the previous section along with the conformational changes (Figure (Figure1B)1B) can explain the observed kinetics of OGDHC. Because the kinetic data we used here to estimate the unknown kinetic parameters were all from the initial velocity studies in which only the products NADH^{2- }and Succinyl-CoA^{- }were present in the reaction mediums, the forward flux of OGDHC can be reduced from Equation (7) as:

$${J}_{ogdhc}^{+}=\frac{{V}_{f}[\text{A][B][C}]}{\left(\begin{array}{l}[\text{A][B][C}]+{K}_{mC}[\text{A][B][R}]/{K}_{ir}\\ +{K}_{mC}[\text{A][B]+}{K}_{mB}[\text{A][C][Q}]/{K}_{iq}\\ +{K}_{mB}[\text{A][C}]+{K}_{ic}{K}_{mB}[\text{A][Q]/}{K}_{iq}\\ +{K}_{mB}{K}_{ic}[\text{A][Q][R}]/{K}_{iq}/{K}_{ir}\\ +{K}_{mA}\text{[B][C}]+{K}_{ia}{K}_{mC}\text{[B][R}]/{K}_{ir}\\ +{K}_{mB}{K}_{ic}{K}_{ia}\text{[Q][R}]/{K}_{iq}/{K}_{ir}\end{array}\right)},$$

(11)

where [A], [B], [C], [R] and [Q] represent the concentrations of *α*KG^{2-}, CoASH^{4-}, NAD^{-}, NADH^{2-}, and Succinyl-CoA^{4-}, respectively. This kinetic expression for OGDHC reaction contains 8 unknown kinetic parameters. Thus, this expression was used first to estimate the 8 unknown kinetic parameters. Using the relationship ${J}_{ogdhc}^{+}/{J}_{ogdhc}^{-}=exp\left(\Delta G/RT\right)$ to determine the reverse flux [35], we obtain the full flux expression for OGDHC as:

$$\begin{array}{ccc}\hfill {J}_{ogdhc}^{}& ={J}_{ogdhc}^{+}-{J}_{ogdhc}^{-}\hfill & \hfill \\ \hfill & ={J}_{ogdhc}^{+}\left(1-\frac{1}{{K}_{eq,ogdhc}^{0}}\frac{\left(\begin{array}{c}\mathsf{\text{[Succinyl-Co}}{\mathsf{\text{A}}}^{4-}{\mathsf{\text{][CO}}}_{\mathsf{\text{3}}}^{\mathsf{\text{2}}-}\mathsf{\text{]}}\\ \mathsf{\text{[NAD}}{\mathsf{\text{H}}}^{\mathsf{\text{2}}-}\mathsf{\text{][}}{\mathsf{\text{H}}}^{\mathsf{\text{+}}}\mathsf{\text{]}}\\ \end{array}\right)}{\left(\mathsf{\text{[}}\alpha \mathsf{\text{K}}{\mathsf{\text{G}}}^{\mathsf{\text{2-}}}\mathsf{\text{][CoAS}}{\mathsf{\text{H}}}^{4-}\mathsf{\text{][NA}}{\mathsf{\text{D}}}^{-}\mathsf{\text{]}}\right)}\right)\hfill \\ \hfill \end{array}$$

(12)

The kinetic expressions for the regulatory effects of various cofactors on OGDHC (which depend on 10 additional kinetic parameters) are parameterized in the Results section, and are estimated separately (see below). Because CO_{2, tot }dependent terms are not included in the denominator in Equation (11), CO_{2, tot }dependent product inhibition is not accounted for in Equation (12).

The developed kinetic model of OGDHC has 8 adjustable parameters for catalytic mechanism and 10 adjustable parameters for cofactor regulation (Table (Table1).1). Parameter values were estimated in a systematic modular manner in multiple steps by least-squares fitting of the model simulated steady-state flux to the available experimental data as detailed in Results section below. The FMINCON algorithm in MATLAB (The MathWorks, Natick, MA) was used to solve this non-linear optimization problem. In addition, sensitivity analysis was performed to estimate the sensitivity of the least square error to small changes in the optimal parameter values. The sensitivity was computed using:

$${S}_{i}=\frac{\mathrm{max}\left(\left|{E}_{i}^{*}({x}_{i}\pm 0.1{x}_{i})-{E}_{i}^{*}({x}_{i})\right|\right)}{0.1{E}_{i}^{*}({x}_{i})},$$

(13)

where *E** is the least square difference between model simulations and experimental data, and *x _{i }*is the optimized value of the

Since all kinetic parameters in the model are measured relative to species concentration, we performed a composition analysis to estimate the concentration of all ionic species all experiments analyzed here [36].

In this section, we present the detailed parameterization and validation of the proposed kinetic model based on the available experimental data on the kinetics of OGDHC, measured in a wide variety of experimental conditions. To study the catalytic mechanism of OGDHC, McMinn and Ottaway [20] investigated the kinetic properties of the OGDHC system, which was prepared from fresh pig heart mitochondria. Following the method of Fromm [21] in which it was concluded from initial velocity studies that the catalytic mechanism of OGDHC is not consistent with the Hexa-Uni-Ping-Pong mechanism. While their observations suggest a random order kinetic mechanism with respect to the binding of NAD^{- }and CoASH^{4- }and release of Succinyl-CoA^{4-}, the binding of 2-oxoglutarate and release of CO_{2 }is described as a Ping-Pong mechanism. Initial velocity kinetics measured by Smith *et al*. [10] with purified pig heart mitochondria OGDHC showed that Succinyl-CoA^{4- }and NADH^{2- }were inhibitors, but no inhibitory effects were observed with GTP or ATP. Their results also show that Succinyl-CoA^{4- }inhibition was competitive with CoASH^{4- }and independent of the NAD^{- }oxidation-reduction state. These data are used here to identify the kinetic parameters of our OGDHC model.

The experimental data in Figure Figure22 were used to estimate the values of unknown kinetic parameters that govern the basic catalytic mechanism of OGDHC (Equation (12)) based on the best fits of the model to the data (See Figure caption for details). Measured enzyme activity is expressed in μmoles NADH^{2- }formed/mg protein/min. We follow a systematic optimization procedure to estimate each kinetic parameter of the model using appropriate experimental data. In the first step, Figure one of McMinn and Ottaway [20] is used to determine the parameters *K _{mA}, K_{mB }*and

Denton *et al*. [23] conducted a number of experiments to study the effects of Ca^{2+}, pH, and adenine nucleotides on the activity of OGDHC from pig heart mitochondria. Their data are used here to identify the kinetic parameters that characterize the activation/inhibition mechanism of Ca^{2+}, pH, and adenine nucleotides (See Figure caption for details). Enzyme activities are expressed as units of enzyme activity per mg of protein. (One unit of activity is the amount of enzyme which transforms 1 μmol of substrate per minute at 30°C).

To fit the data that describe the regulatory effects of Ca^{2+ }from Figures Figures33 and and44 of Denton *et al*. [23], it is necessary to account for mechanisms of allosteric activation/inhibition of Ca^{2+ }in the model. It has been shown that Ca^{2+ }can significantly affect the function of OGDHC by modulating the enzyme affinity for 2-oxoglutarate, showing a sigmoidal kinetics. Here we propose a general scheme of nonessential and mixed-type activation to characterize the effects of Ca^{2+}. Based on this scheme, we assume the presence of two binding sites for Ca^{2+ }on OGDHC and modify *V*_{max }and *K _{m }*of the enzyme complex for 2-oxoglutarate as follows:

$$\begin{array}{c}{V}_{max,1}={V}_{max,0}\left(\frac{1+\frac{{\beta}_{Ca}\left[\mathsf{\text{C}}{\mathsf{\text{a}}}^{\mathsf{\text{2+}}}\right]}{{\alpha}_{Ca}{K}_{aCa}}+\frac{{\beta}_{Ca}{\left[\mathsf{\text{C}}{\mathsf{\text{a}}}^{\mathsf{\text{2+}}}\right]}^{2}}{{\left({\alpha}_{Ca}{K}_{aCa}\right)}^{2}}}{1+\frac{\left[\mathsf{\text{C}}{\mathsf{\text{a}}}^{\mathsf{\text{2+}}}\right]}{{\alpha}_{Ca}{K}_{aCa}}+\frac{{\left[\mathsf{\text{C}}{\mathsf{\text{a}}}^{\mathsf{\text{2+}}}\right]}^{2}}{{\left({\alpha}_{Ca}{K}_{aCa}\right)}^{2}}}\right),\mathsf{\text{}}\\ {K}_{mA,1}={K}_{mA,0}\left(\frac{1+\frac{\left[\mathsf{\text{C}}{\mathsf{\text{a}}}^{\mathsf{\text{2+}}}\right]}{{K}_{aCa}}+\frac{{\left[\mathsf{\text{C}}{\mathsf{\text{a}}}^{\mathsf{\text{2+}}}\right]}^{2}}{{K}_{aCa}^{2}}}{1+\frac{\left[\mathsf{\text{C}}{\mathsf{\text{a}}}^{\mathsf{\text{2+}}}\right]}{{\alpha}_{Ca}{K}_{aCa}}+\frac{{\left[\mathsf{\text{C}}{\mathsf{\text{a}}}^{\mathsf{\text{2+}}}\right]}^{2}}{{\left({\alpha}_{Ca}{K}_{aCa}\right)}^{2}}}\right).\\ \end{array}$$

(14)

The modified flux expression for OGDHC is obtained by substituting Equation (14) into Equation (11). Three adjustable parameters (*α _{Ca}, β_{Ca}*, and

Experimentally it has been shown that the maximal activity of OGDHC is largely unaffected by changes in pH over the range 6.6-7.4, whereas the *K*_{m }of the enzyme is markedly altered by pH in this range [23]. In our model, the effect of pH on the OGDHC activity was described based on the observations studies of Denton and colleagues [23]. Here, protons are treated as the essential activators of OGDHC which increase the binding affinity of the enzyme to 2-oxoglutarate. Therefore, the *K _{m }*of 2-oxoglurate is modified by multiplying the term

Denton and colleagues [23] also studied the effect of adenine nucleotides (ATP and ADP) on the OGDHC activity where it was shown that both ATP and ADP significantly impact the *K*_{m }of the en-zyme for 2-oxoglutarate and that the regulations of OGDHC by Ca^{2+ }and adenine nucleotides seem to be independent. Here the regulatory effects of nucleotides on OGDHC activity is modeled as similar to that of Ca^{2+}. Specifically, we assume that there are different binding sites on the OGDHC that bind to ATP or ADP. (The available kinetic data cannot exclude the other possibility that ATP and ADP can bind at the same site.) Therefore, the *V*_{max }and *K _{m }*for 2-oxoglutarate was modified as a function of nucleotide concentrations as follows:

$$\begin{array}{l}{V}_{\mathrm{max},2}={V}_{\mathrm{max},1}\frac{\left(1+\frac{{\beta}_{ATP}{[\text{ATP}]}_{\text{T}}}{{\alpha}_{ATP}{K}_{ATP}}\right)\left(1+\frac{{\beta}_{ADP}{[\text{ADP}]}_{\text{T}}}{{\alpha}_{ADP}{K}_{aADP}}\right)}{\left(1+\frac{{[\text{ATP}]}_{\text{T}}}{{\alpha}_{ATP}{K}_{ATP}}\right)\left(1+\frac{{[\text{ADP}]}_{\text{T}}}{{\alpha}_{ADP}{K}_{aADP}}\right)},\\ {K}_{mA,2}={K}_{mA,1}\frac{\left(1+\frac{{\text{[ATP}]}_{\text{T}}}{{K}_{iATP}}\right)\left(1+\frac{{[\text{ADP}]}_{\text{T}}}{{K}_{aADP}}\right)}{\left(1+\frac{{[\text{ATP}]}_{\text{T}}}{{\alpha}_{ATP}{K}_{iATP}}\right)\left(1+\frac{{[\text{ADP}]}_{\text{T}}}{{\alpha}_{ADP}{K}_{ADP}}\right)}\frac{{K}_{aH}}{[{\text{H}}^{\text{+}}]}\end{array}$$

(15)

where [ATP]_{T }and [ADP]_{T }represent the total concentrations of the nucleotides. Experimental results show that neither free nucleotides nor magnesium binding nucleotides are solely responsible for activation observed. More data are needed to quantitatively and qualitatively specify the activation effects of each nucleotide's ionic forms. Figure 4(A-C) are model fits to the data obtained from Figures Figures55 and and66 of Denton and colleagues [23]. Optimization results based on these data indicate that both ATP and ADP change the *K _{m }*of OGDHC for 2-oxoglutarate without altering the maximum activity, which suggests that both

Mg^{2+ }is known to regulate the activity of OGDHC. In a recent study, Rodriguez-Zavala *et al*. [37] examined the effects of ligands, such as ATP, ADP, Ca^{2+}, and Mg^{2+ }on the activity of OGDHC in both isolated pig heart enzyme complex and mitochondrial extracts. These data facilitate the characterization of the regulatory effect of Mg^{2+ }on the OGDHC activity and are used here to estimate the Mg^{2+ }associated kinetic parameters. Enzyme activity is measured in nmol NADH^{2+ }formed per minute per mg protein.

Experimental data from purified OGDHC from pig heart mitochondria from Rodriguez-Zavala *et al*. [37] with zero Mg^{2+ }were used to estimate the *V*_{max }of the enzyme. Figure Figure5B5B shows the model simulations (lines) using the parameter estimates obtained above, with the exception that *V*_{max }was adjusted to match these experimental data. Data in Figure Figure5A5A with non-zero Mg^{2+ }concentration and the data in Figure Figure5C5C are then used to estimate the kinetic parameters associated with the binding of Mg^{2+}. Our model fits to these data assume that Mg^{2+ }not only increases the activity by binding to the enzyme complex, but also potentiates the 2-oxoglutarate affinity to the enzyme and decrease the *K _{m }*of OGDHC for 2-oxoglutarate. Specifically, we assume two binding sites for Mg

$$\begin{array}{l}{V}_{\mathrm{max},3}={V}_{\mathrm{max},2}\left(\frac{1+\frac{{\beta}_{Mg}[{\text{Mg}}^{\text{2+}}]}{{\alpha}_{Mg}{K}_{aMg}}+\frac{{\beta}_{Mg}{[{\text{Mg}}^{\text{2+}}]}^{2}}{{\left({\alpha}_{Mg}{K}_{aMg}\right)}^{2}}}{1+\frac{[{\text{Mg}}^{\text{2+}}]}{{\alpha}_{Mg}{K}_{aMg}}+\frac{{[{\text{Mg}}^{\text{2+}}]}^{2}}{{\left({\alpha}_{Mg}{K}_{aMg}\right)}^{2}}}\right),\\ {K}_{mA,3}={K}_{mA,2}\left(\frac{1+\frac{{\text{[Mg}}^{\text{2+}}]}{{K}_{aMg}}+\frac{{{\text{[Mg}}^{\text{2+}}]}^{2}}{{K}_{aMg}^{2}}}{1+\frac{[{\text{Mg}}^{\text{2+}}]}{{\alpha}_{Mg}{K}_{aMg}}+\frac{{[{\text{Mg}}^{\text{2+}}]}^{2}}{{\left({\alpha}_{Mg}{K}_{aMg}\right)}^{2}}}\right)\end{array}$$

(16)

The data shown in Figure Figure55 are used to estimate the adjustable kinetic parameters related to Mg^{2+ }ions in our kinetic model for OGDHC. Fits to the data are plotted in Figure Figure55 and the parameter values summarized in Table Table1.1. The developed model is able to satisfactorily explain the effect of Mg^{2+ }ions on the enzyme activity. These results, combined with those shown in Figures Figures22 and and3,3, imply that the matrix free Ca^{2+ }and Mg^{2+ }ions concentrations exert significant and distinct effects on the OGDHC activity.

Based on the proposed mechanisms of allosteric activation and inhibition of various cofactors, the flux expression (Equation (11)) of the OGDHC can be further modified. Applying the catalytic and regulatory mechanisms of Equations 14-16, the final forward flux expression is

$${J}_{ogdhc}^{+}=\frac{{V}_{f}[\text{A][B][C}]N\left(\begin{array}{l}[\text{A][B][C}]+\frac{1}{{K}_{ir}}{K}_{mC}[\text{A][B][R}]\\ +{K}_{mC}[\text{A][B]+}\frac{1}{{K}_{iq}}{K}_{mB}[\text{A][C][Q}]\\ +{K}_{mB}[\text{A][C}]+\frac{{K}_{mB}{K}_{ic}}{{K}_{iq}{K}_{ir}}[\text{A][Q][R}]\\ +\frac{{K}_{ic}}{{K}_{iq}}{K}_{mB}[\text{A][Q]}+{K}_{mA}\text{[B][C}]{\alpha}_{A}\\ +\frac{{K}_{ia}}{{K}_{ir}}{K}_{mC}\text{[B][R}]+\frac{{K}_{mB}{K}_{ic}{K}_{ia}}{{K}_{iq}{K}_{ir}}\text{[Q][R}]\end{array}\right)}{}$$

(17)

where ${\alpha}_{A}=\frac{\begin{array}{l}\left(1+\frac{[{\text{Ca}}^{\text{2+}}]}{{K}_{aCa}}+\frac{{[{\text{Ca}}^{\text{2+}}]}^{2}}{{K}_{aCa}^{2}}\right)\times \left(1+\frac{{\text{[ATP}]}_{\text{T}}}{{K}_{iATP}}\right)\\ \times \left(1+\frac{{[\text{ADP}]}_{\text{T}}}{{K}_{aADP}}\right)\times \left(1+\frac{{\text{[Mg}}^{\text{2+}}]}{{K}_{aMg}}+\frac{{{\text{[Mg}}^{\text{2+}}]}^{2}}{{K}_{aMg}^{2}}\right)\end{array}}{\begin{array}{l}\left(1+\frac{[{\text{Ca}}^{\text{2+}}]}{{\alpha}_{Ca}{K}_{aCa}}+\frac{{[{\text{Ca}}^{\text{2+}}]}^{2}}{{\alpha}_{Ca}^{2}{K}_{aCa}^{2}}\right)\times \left(1+\frac{{[\text{ATP}]}_{\text{T}}}{{\alpha}_{ATP}{K}_{iATP}}\right)\\ \times \left(1+\frac{{[\text{ADP}]}_{\text{T}}}{{\alpha}_{ADP}{K}_{ADP}}\right)\times \left(1+\frac{[{\text{Mg}}^{\text{2+}}]}{{\alpha}_{Mg}{K}_{aMg}}+\frac{{[{\text{Mg}}^{\text{2+}}]}^{2}}{{\alpha}_{Mg}^{2}{K}_{aMg}^{2}}\right)\end{array}}\times \left(\frac{{K}_{aH}}{[{\text{H}}^{\text{+}}]}\right)$

and $N=\frac{\left(1+\frac{{\beta}_{Mg}\left[\mathsf{\text{M}}{\mathsf{\text{g}}}^{\mathsf{\text{2+}}}\right]}{{\alpha}_{Mg}{K}_{aMg}}+\frac{{\beta}_{Mg}^{}{\left[\mathsf{\text{M}}{\mathsf{\text{g}}}^{\mathsf{\text{2+}}}\right]}^{2}}{{\left({\alpha}_{Mg}{K}_{aMg}\right)}^{2}}\right)}{\left(1+\frac{\left[\mathsf{\text{M}}{\mathsf{\text{g}}}^{\mathsf{\text{2+}}}\right]}{{\alpha}_{Mg}{K}_{aMg}}+\frac{{\left[\mathsf{\text{M}}{\mathsf{\text{g}}}^{\mathsf{\text{2+}}}\right]}^{2}}{{\left({\alpha}_{Mg}{K}_{aMg}\right)}^{2}}\right)}.$

Estimated values of *K _{aH}, K_{iATP}, K_{aADP}, K_{aMg}, α_{ADP}, α_{ATP}, α_{Ca}, α_{Mg}*, and

Finally, the model is independently validated (corroborated) by comparing the model predictions to the initial rate data of Rutter and Denton [38] on the kinetics of OGDHC obtained from permeabilized mitochondria and mitochondrial extracts (see Figure 6(A-C)). They studied the regulations of NAD-linked isocitrate dehydrogenase and 2-oxoglutarate dehydrogenase by Ca^{2+}, nucleotide and nicotinamide nucleotides in permeabilized rat heart mitochondria and in mitochondria extracts. Data from their study were not used for estimation of model parameters and used here to further validate the proposed mechanisms and regulation of OGDHC. Therefore, the flux expression of Equation (17) was used for simulations with the values of the kinetic parameters the same as estimated before (see Table Table1).1). The model accurately describes the kinetics and regulation of OGDHC, observed experimentally, without having to re-estimate the model kinetic parameters, signifying the accuracy of the model and the associated model parameters.

To determine the degree to which the model simulations are sensitive to the estimated parameter values, the relative sensitivities are computed and listed in Table Table1.1. A high sensitivity value indicates that a small change in a given parameter can lead to significant changes in model outputs, used to identify the parameter values. All of our adjustable parameters of the model have sensitivities over 30%. Two parameter estimates (*K _{aCa }*and

A number of kinetic models have been previously developed to explain the basic catalytic mechanisms and regulations by cofactors of OGDHC. Sanadi *et al*. [12] first proposed a Hexa-Uni-Ping-Pong mechanism for the overall reaction by studying various roles and locations of the cofactors: thiamine pyrophosphate, lipoic acid, and FAD^{2- }within this complex. Hemada *et al*. [19] conducted kinetic studies and proposed a similar mechanism to that of Sandi *et al*. and suggested that NADH^{2- }is a competitive inhibitor of NAD^{-}. Whereas Smith *et al*. [10] suggested a noncompetitive inhibition of NADH^{2- }with NAD^{-}, the catalytic mechanism was not consistent with Sandi *et al*. Later, McMinn and Ottaway [20] tested a series of possible alternate mechanisms using computer optimization techniques and initial velocity studies and concluded that the binding of NAD^{- }and CoASH^{4- }and the release of Succinyl-CoA^{4- }is a random order, whereas the binding of the substrate 2-oxoglutarate and release of the product CO_{2 }still follows a Ping-Pong mechanism. Besides above experimental studies, a number of integrated models of mitochondrial bioenergetics have been developed which used different type of OGDHC models. Cortassa *et al*. [39] describe the activity of OGDHC as a function of Ca^{2+}, Mg^{2+ }and substrate concentrations using phenomenological terms. Wu *et al*. [40] used a simple kinetic model of OGDHC from Kohn and Garfinkel [41] in their integrated model of TCA cycle that does not incorporate the regulatory effect of metal ion cofactors. In a recent integrated study of mitochondrial bioenergetics, Bazil *et al*. [42] developed a kinetic model of OGDHC based on a Hexa-Uni-Ping-Pong mechanism with a general description of the cofactor dependency of OGDHC activity. In summary, there have been a wide variety of kinetic models of OGDHC with contrasting kinetic mechanism and cofactor regulations.

In this paper, we developed a unified mechanistic model of OGDHC, in which Ca^{2+}, Mg^{2+}, ADP^{3-}, and pH are treated as activators and ATP^{4- }as inhibitor of the OGDHC activity. The present model offers more realistic and meaningful explanations on the catalytic properties and regulation mechanisms of OGDHC than previous attempts. The analysis also provides a unique set of kinetic parameters that consistently describe a wide variety of experimental data sets on OGDHC function, obtained from diverse sources. Based on the assumed ter-ter mechanism and associated conformational changes, we are able to consistently reproduce the observed kinetics of OGDHC with a minimal number of model parameters. Thus, the proposed mechanism is found to be more appropriate compared to other alternate kinetic models [43].

Energy-linked regulators, ADP and ATP, as well as inorganic phosphate, have been investigated for over two decades for their profound effects on kinetic properties of OGDHC. Kinetic studies of mammalian OGDHC, isolated from varied sources, have shown that ADP causes activation of OGDHC [44-47]. This enzyme complex is sensitive to ADP, where ADP significantly decreases the *K _{m }*for 2-oxogluterate without affecting the maximum rate (

While Zavala *et al*. interpret the data of Figure Figure5A5A to indicate that MgADP^{- }is the effective activator of OGDHC activity, our model analysis of the available data sets on Mg^{2+}, ADP, and ATP dependent kinetics (Figures (Figures44 and Figure Figure5B5B and and5C)5C) reveals that, magnesium and ADP have independent parallel effects on the OGDHC activity, the most parsimonious explanation of the data. However, al-ternative, more complex, models cannot be ruled out.

Like ADP, Pi has also been shown to decrease the *K _{m }*value for 2-oxogutarate, without affecting the

Mitochondrial matrix proton (H^{+ }ion) concentration is known to affect the OGDHC properties. Specifically, studies on pig heart OGDHC showed that the change in pH in the range 6.6 to 7.4 can significantly alter *K _{m }*of the enzyme for 2-oxogluterate, without affecting its maximal activity. McCormack and Denton illustrated the effect of pH on OGDHC activity both in the absence and presence of Ca

Studies by McCormack and Denton demonstrate the activating effects of Ca^{2+ }ions on intra-mitochondrial dehydrogenases: pyruvate (PDH), NAD-isocitrate (NAD-ICDH), and 2-oxoglutarate (OGDHC) [24,54,55]. Specifically, the rise in cytosolic Ca^{2+ }concentration in response to extrinsic stimuli, such as hormones can enhance mitochondrial oxidative metabolism via direct activation of these three Ca^{2+ }sensitive dehydrogenases. Such mechanisms may serve as a complementary way to stimulate ATP-synthesis to meet the increased energy demand of the cell [24,54,55].

Mg^{2+ }ion has also been shown to regulate the OGDHC activity either by directly activating the enzyme or by modulating the Ca^{2+ }effects on the enzyme. In some studies, Mg^{2+ }shows no effects on OGDHC activity [23]. However, in other studies, Mg^{2+ }is shown to increase the maximal activity of the enzyme and the affinity of OGDHC for 2-oxogluterate by enhancing the Ca^{2+ }stimulatory effects on the enzyme complex [9,25,37]. These different observations could be accounted for the different levels of endogenous Ca^{2+ }and Mg^{2+ }present in the purified enzyme complex prepared by different methods. Another possible explanation is that the stimulatory effects of Mg^{2+ }is TPP-dependent, which is not explicitly considered in our model. Panov and Scarpa [9] found that Mg^{2+ }only exerts its stimulatory effects in the presence of TPP, though exclusion of TPP from the reaction medium has no effect on the initial enzyme activity in the absence of Mg^{2+}. Also, it has been clearly shown that Mg^{2+ }may affect the rate of oxidative phosphorylation in isolated mitochondria primarily via modulating the OGDHC activity [25]. The site of action of Mg^{2+ }ion on OGDHC is unknown. In the present model, we hypothesized a general scheme of nonessential activation of Ca^{2+}, by considering two Ca^{2+ }and Mg^{2+ }binding sites on OGDHC. The Mg^{2+ }effect is incorporated in our model by exclusively modifying the enzyme activity and 2-oxoglutarate binding step. So the parameters *V*_{max }and *K _{mA }*are accordingly expressed as functions of Mg

EGTA, which is used in many studies to control Ca^{2+ }ion concentration in reaction media, has been shown in experiments and theoretical analysis to inhibit the NAD-linked isocitrate dehydrogenases (ICDH) through the binding complex, MgEGTA [36]. To date, it is still not clear if there is similar inhibition effect of EGTA or EDTA on the activity of OGDHC. McCormack and Denton [23] concluded that the OGDHC sensitivity toEGTA is very similar to that observed with ICDH [56], because addition of calcium chelators EGTA or EDTA is associated with a marked decrease in the activity of OGDHC at 0.2 mM 2-oxoglutarate. Panov and Scarpa [9], in ascribing the inhibition effect of EGTA to the complex formation between Ca^{2+ }and chelators, concluded that the effected of Ca^{2+ }and chelators is associated with different endogenous cation levels in different preparations. But this explanation cannot account for McCormack and Denton's observation that EGTA or EDTA causes a 40% decrease of activity of OGDHC after using Chelex remove much of the endogenous Ca^{2+ }in the buffer. It is also noted that the *K _{M }*for 2-oxoglutarate in the absence of Ca

Our mechanistic OGDHC model based on a detailed catalytic mechanism successfully provides a single consistent theoretical explanation for many previously unresolved experimental observations on the kinetics and regulations of OGDHC. In particular, it suggests the most plausible physiologically regulations of OGDHC by NAD(H) oxidation-reduction state, the nucleotide phosphorylation potential, pH and various metal ions (Mg^{2+ }and Ca^{2+}). As a rise in NADH can reduce the OGDHC flux and thereby provides feedback regulation through the electron transport chain, it is important to ask how NAD oxidation-reduction state and oxidative phosphorylation state exert a coherent regulation of OGDHC in physiological context. Furthermore, how does the OGDHC respond to stimuli via the mitochondrial Ca^{2+ }transport system? Such questions may be addressed by applying the present model in an integrated framework [43] along with other dehydrogenases [36], the oxidative phosphorylation system [57], electron transfer system [58], and cation transport systems [59-61].

FQ conceived the basic idea, collected experimental data set, developed the model, analyzed data and drafted the manuscript. RKP helped to collect and analyze the data and drafted the manuscript. RKD and DAB advised the study and revised the manuscript. All authors read and approved the final manuscript.

The authors thank Doug Disabato for participating in the initial part of the model development and gathering available experimental data for the analysis, Fan Wu, Kalyan Vinnakota, and Jason Bazil for helpful discussion. This work was supported by NIH grants R01-HL072011 and R01-HL095122.

- Tretter L, Adam-Vizi V. Alpha-ketoglutarate dehydrogenase: a target and generator of oxidative stress. Philos Trans R Soc Lond B Biol Sci. 2005;360(1464):2335–2345. doi: 10.1098/rstb.2005.1764. [PMC free article] [PubMed] [Cross Ref]
- Perham RN. Domains, motifs, and linkers in 2-oxo acid dehydrogenase multienzyme complexes: a paradigm in the design of a multifunctional protein. Biochemistry. 1991;30(35):8501–8512. doi: 10.1021/bi00099a001. [PubMed] [Cross Ref]
- Strumilo S. Often ignored facts about the control of the 2-oxoglutarate dehydrogenase complex. Biochemistry and Molecular Biology Education. 2005;33(4):284–287. doi: 10.1002/bmb.2005.49403304284. [Cross Ref]
- Sanadi DR, Littlefield JW, Bock RM. Studies on alpha-ketoglutaric oxidase. II. Purification and properties. J Biol Chem. 1952;197(2):851–862. [PubMed]
- Denton RM, McCormack JG, Edgell NJ. Role of calcium ions in the regulation of intramitochondrial metabolism. Effects of Na+, Mg2+ and ruthenium red on the Ca2+-stimulated oxidation of oxoglutarate and on pyruvate dehydrogenase activity in intact rat heart mitochondria. Biochem J. 1980;190(1):107–117. [PubMed]
- Hansford RG, Castro F. Role of Ca2+ in pyruvate dehydrogenase interconversion in brain mitochondria and synaptosomes. Biochem J. 1985;227(1):129–136. [PubMed]
- McCormack JG, Bromidge ES, Dawes NJ. Characterization of the effects of Ca2+ on the intramitochondrial Ca2+-sensitive dehydrogenases within intact rat-kidney mitochondria. Biochim Biophys Acta. 1988;934(3):282–292. doi: 10.1016/0005-2728(88)90088-6. [PubMed] [Cross Ref]
- McCormack JG, Denton RM. The role of Ca
^{2+ }ions in the regulation of intramitochondrial metabolism and energy production in rat heart. Mol Cell Biochem. 1989;89(2):121–125. [PubMed] - Panov A, Scarpa A. Independent modulation of the activity of alpha-ketoglutarate dehy-drogenase complex by Ca2+ and Mg2+ Biochemistry. 1996;35(2):427–432. doi: 10.1021/bi952101t. [PubMed] [Cross Ref]
- Smith CM, Bryla J, Williamson JR. Regulation of mitochondrial alpha-ketoglutarate metabolism by product inhibition at alpha-ketoglutarate dehydrogenase. J Biol Chem. 1974;249(5):1497–1505. [PubMed]
- Starkov AA, Fiskum G, Chinopoulos C, Lorenzo BJ, Browne SE, Patel MS, Beal MF. Mito-chondrial alpha-ketoglutarate dehydrogenase complex generates reactive oxygen species. J Neurosci. 2004;24(36):7779–7788. doi: 10.1523/JNEUROSCI.1899-04.2004. [PubMed] [Cross Ref]
- Sanadi DR. Enzymes. 2. 7. 1963. pp. 307–344.
- Massey V. The composition of the ketoglutarate dehydrogenase complex. Biochim Biophys Acta. 1960;38:447–460. [PubMed]
- Cleland WW. The kinetics of enzyme-catalyzed reactions with two or more substrates or products. I. Nomenclature and rate equations. Biochim Biophys Acta. 1963;67:104–137. [PubMed]
- Koike M, Reed LJ, Carroll WR. alpha-Keto acid dehydrogenation complexes. IV. Resolution and reconstitution of the Escherichia coli pyruvate dehydrogenation complex. J Biol Chem. 1963;238:30–39. [PubMed]
- Angelides KJ, Hammes GG. Mechanism of action of the pyruvate dehydrogenase multienzyme complex from Escherichia coli. Proc Natl Acad Sci USA. 1978;75(10):4877–4880. doi: 10.1073/pnas.75.10.4877. [PubMed] [Cross Ref]
- Waskiewicz DE, Hammes GG. Fluorescence polarization study of the alpha-ketoglutarate dehydrogenase complex from Escherichia coli. Biochemistry. 1982;21(25):6489–6496. doi: 10.1021/bi00268a026. [PubMed] [Cross Ref]
- Angelides KJ, Hammes GG. Structural and mechanistic studies of the alpha-ketoglutarate dehydrogenase multienzyme complex from Escherichia coli. Biochemistry. 1979;18(25):5531–5537. doi: 10.1021/bi00592a001. [PubMed] [Cross Ref]
- Hamada M, Koike K, Nakaula Y, Hiraoka T, Koike M. A kinetic study of the alpha-keto acid dehydrogenase complexes from pig heart mitochondria. J Biochem. 1975;77(5):1047–1056. [PubMed]
- McMinn CL, Ottaway JH. Studies on the mechanism and kinetics of the 2-oxoglutarate dehydrogenase system from pig heart. Biochem J. 1977;161(3):569–581. [PubMed]
- Fromm HJ. The use of competitive inhibitors in studying the mechanism of action of some enzyme systems utilizing three substrates. Biochim Biophys Acta. 1967;139(2):221–230. [PubMed]
- Aevarsson A, Seger K, Turley S, Sokatch JR, Hol WG. Crystal structure of 2-oxoisovalerate and dehydrogenase and the architecture of 2-oxo acid dehydrogenase multienzyme complexes. Nat Struct Biol. 1999;6(8):785–792. doi: 10.1038/11563. [PubMed] [Cross Ref]
- McCormack JG, Denton RM. The effects of calcium ions and adenine nucleotides on the activity of pig heart 2-oxoglutarate dehydrogenase complex. Biochem J. 1979;180(3):533–544. [PubMed]
- McCormack JG, Denton RM. Role of Ca
^{2+ }ions in the regulation of intramitochondrial metabolism in rat heart. Evidence from studies with isolated mitochondria that adrenaline activates the pyruvate dehydrogenase and 2-oxoglutarate dehydrogenase complexes by increasing the intramitochondrial concentration of Ca^{2+}Biochem J. 1984;218(1):235–247. [PubMed] - Rodriguez-Zavala JS, Moreno-Sanchez R. Modulation of oxidative phosphorylation by Mg2+ in rat heart mitochondria. J Biol Chem. 1998;273(14):7850–7855. doi: 10.1074/jbc.273.14.7850. [PubMed] [Cross Ref]
- Hayakawa T, Kanzaki T, Kitamura T, Fukuyoshi Y, Sakurai Y, Koike K, Suematsu T, Koike M. Mammalian alpha-keto acid dehydrogenase complexes. V. Resolution and reconstitution studies of the pig heart pyruvate dehydrogenase complex. J Biol Chem. 1969;244(13):3660–3670. [PubMed]
- Hirashima M, Hayakawa T, Koike M. Mammalian alpha-keto acid dehydrogenase complexes. II. An improved procedure for the preparation of 2-oxoglutarate dehydrogenase complex from pig heart muscle. J Biol Chem. 1967;242(5):902–907. [PubMed]
- Patel MS. Inhibition by the branched-chain 2-oxo acids of the 2-oxoglutarate dehydrogenase complex in developing rat and human brain. Biochem J. 1974;144(1):91–97. [PubMed]
- Lai JC, Cooper AJ. Brain alpha-ketoglutarate dehydrogenase complex: kinetic properties, regional distribution, and effects of inhibitors. J Neurochem. 1986;47(5):1376–1386. doi: 10.1111/j.1471-4159.1986.tb00768.x. [PubMed] [Cross Ref]
- Shylaja N, Maehara M, Watanabe K. Measurement of alpha-ketoglutarate dehydrogenase activity in tissue extracts and human platelets using reversed-phase high-performance liquid chromatography. Anal Biochem. 1990;191(2):223–227. doi: 10.1016/0003-2697(90)90211-Q. [PubMed] [Cross Ref]
- Northrop DB. Transcarboxylase. VI. Kinetic analysis of the reaction mechanism. J Biol Chem. 1969;244(21):5808–5819. [PubMed]
- Qi F, Dash RK, Han Y, Beard DA. Generating rate equations for complex enzyme systems by a computer-assisted systematic method. BMC Bioinformatics. 2009;10:238. doi: 10.1186/1471-2105-10-238. [PMC free article] [PubMed] [Cross Ref]
- Segel IH. Enzyme kinetics: behavior and analysis of rapid equilibrium and steady-state enzyme systems. New York: Wiley; 1975.
- Li X, Dash RK, Pradhan RK, Qi F, Thompson M, Vinnakota KC, Wu F, Yang F, Beard DA. A database of thermodynamic quantities for the reactions of glycolysis and the tricarboxylic acid cycle. J Phys Chem B. 2010;114(49):16068–16082. doi: 10.1021/jp911381p. [PMC free article] [PubMed] [Cross Ref]
- Beard DA, Qian H. Relationship between thermodynamic driving force and one-way fluxes in reversible processes. PLoS ONE. 2007;2(1):e144. doi: 10.1371/journal.pone.0000144. [PMC free article] [PubMed] [Cross Ref]
- Qi F, Chen X, Beard DA. Detailed kinetics and regulation of mammalian NAD-linked isocitrate dehydrogenase. Biochim Biophys Acta. 2008;1784(11):1641–1651. [PMC free article] [PubMed]
- Rodriguez-Zavala JS, Pardo JP, Moreno-Sanchez R. Modulation of 2-oxoglutarate dehydrogenase complex by inorganic phosphate, Mg(2+), and other effectors. Arch Biochem Biophys. 2000;379(1):78–84. doi: 10.1006/abbi.2000.1856. [PubMed] [Cross Ref]
- Rutter GA, Denton RM. Regulation of NAD+-linked isocitrate dehydrogenase and 2-oxoglutarate dehydrogenase by Ca2+ ions within toluene-permeabilized rat heart mitochondria. Interactions with regulation by adenine nucleotides and NADH/NAD+ ratios. Biochem J. 1988;252(1):181–189. [PubMed]
- Cortassa S, Aon MA, Marban E, Winslow RL, O'Rourke B. An integrated model of cardiac mitochondrial energy metabolism and calcium dynamics. Biophys J. 2003;84(4):2734–2755. doi: 10.1016/S0006-3495(03)75079-6. [PubMed] [Cross Ref]
- Wu F, Yang F, Vinnakota KC, Beard DA. Computer modeling of mitochondrial tricarboxylic acid cycle, oxidative phosphorylation, metabolite transport, and electrophysiology. J Biol Chem. 2007;282(34):24525–24537. doi: 10.1074/jbc.M701024200. [PubMed] [Cross Ref]
- Kohn MC, Garfinkel D. Computer simulation of metabolism in palmitate-perfused rat heart. II. Behavior of complete model. Ann Biomed Eng. 1983;11(6):511–531. doi: 10.1007/BF02364082. [PubMed] [Cross Ref]
- Bazil JN, Buzzard GT, Rundell AE. Modeling mitochondrial bioenergetics with integrated volume dynamics. PLoS Comput Biol. 2010;6(1):e1000632. doi: 10.1371/journal.pcbi.1000632. [PMC free article] [PubMed] [Cross Ref]
- Beard DA. Simulation of cellular biochemical system kinetics. Wiley Interdiscip Rev Syst Biol Med. 2010;3(2):136–146. [PMC free article] [PubMed]
- Lawlis VB, Roche TE. Regulation of bovine kidney alpha-ketoglutarate dehydrogenase complex by calcium ion and adenine nucleotides. Effects on S0.5 for alpha-ketoglutarate. Biochemistry. 1981;20(9):2512–2518. doi: 10.1021/bi00512a023. [PubMed] [Cross Ref]
- Lawlis VB, Roche TE. Inhibition of bovine kidney alpha-ketoglutarate dehydrogenase complex by reduced nicotinamide adenine dinucleotide in the presence or absence of calcium ion and effect of adenosine 5'-diphosphate on reduced nicotinamide adenine dinucleotide inhibition. Biochemistry. 1981;20(9):2519–2524. doi: 10.1021/bi00512a024. [PubMed] [Cross Ref]
- McCormack JG, Denton RM. A comparative study of the regulation of Ca
^{2+ }of the activities of the 2-oxoglutarate dehydrogenase complex and NAD^{+}-isocitrate dehydrogenase from a variety of sources. Biochem J. 1981;196(2):619–624. [PubMed] - Nichols BJ, Rigoulet M, Denton RM. Comparison of the effects of Ca2+, adenine nucleo-tides and pH on the kinetic properties of mitochondrial NAD(+)-isocitrate dehydrogenase and oxoglutarate dehydrogenase from the yeast Saccharomyces cerevisiae and rat heart. Biochem J. 1994;303(Pt 2):461–465. [PubMed]
- Ostrovtsova SA, Strumilo SA. Participation of adenosine diphosphate in regulation of the 2-oxoglutarate dehydrogenase complex from human heart. Biomed Biochim Acta. 1990;49(6):515–517. [PubMed]
- Strumilo SA, Taranda NI, Vinogradov VV. Peculiarities of the regulation of adrenal oxoglutarate dehydrogenase complex by NADH and adenosine diphosphate. Biokhimiia. 1982;47(5):724–732. [PubMed]
- Strumilo SA, Taranda NI, Vinogradov VV. Role of phosphate and divalent metal ions in regulation of the activity of the alpha-ketoglutarate dehydrogenase complex from adrenal cortex. Biokhimiia. 1981;46(1):156–161. [PubMed]
- Beard DA, Kushmerick MJ. Strong inference for systems biology. PLoS Comput Biol. 2009;5(8):e1000459. doi: 10.1371/journal.pcbi.1000459. [PMC free article] [PubMed] [Cross Ref]
- Wu F, Zhang EY, Zhang J, Bache RJ, Beard DA. Phosphate metabolite concentrations and ATP hydrolysis potential in normal and ischaemic hearts. J Physiol. 2008;586(17):4193–4208. doi: 10.1113/jphysiol.2008.154732. [PubMed] [Cross Ref]
- Pawelczyk T, Angielski S. Cooperation of Ca2+ and pH in regulation of the activity of the 2-oxoglutarate dehydrogenase complex and its components from bovine kidney cortex. Acta Biochim Pol. 1984;31(3):289–305. [PubMed]
- McCormack JG, Denton RM. Influence of calcium ions on mammalian intramitochondrial dehydrogenases. Methods Enzymol. 1989;174:95–118. [PubMed]
- Denton RM, McCormack JG. Ca
^{2+ }transport by mammalian mitochondria and its role in hormone action. Am J Physiol. 1985;249(6 Pt 1):E543–554. [PubMed] - Denton RM, Richards DA, Chin JG. Calcium ions and the regulation of NAD+-linked isocitrate dehydrogenase from the mitochondria of rat heart and other tissues. The Biochemical journal. 1978;176(3):899–906. [PubMed]
- Beard DA. A Biophysical Model of the Mitochondrial Respiratory System and Oxidative Phosphorylation. PLoS Comput Biol. 2005;1(4):e36. doi: 10.1371/journal.pcbi.0010036. [PubMed] [Cross Ref]
- Chen X, Qi F, Dash RK, Beard DA. Kinetics and regulation of mammalian NADH-ubiquinone oxidoreductase (Complex I) Biophys J. 2010;99(5):1426–1436. doi: 10.1016/j.bpj.2010.06.063. [PubMed] [Cross Ref]
- Dash RK, Qi F, Beard DA. A biophysically based mathematical model for the kinetics of mitochondrial calcium uniporter. Biophys J. 2009;96(4):1318–1332. doi: 10.1016/j.bpj.2008.11.005. [PubMed] [Cross Ref]
- Pradhan RK, Beard DA, Dash RK. A biophysically based mathematical model for the kinetics of mitochondrial Na+-Ca2+ antiporter. Biophys J. 2010;98(2):218–230. doi: 10.1016/j.bpj.2009.10.005. [PubMed] [Cross Ref]
- Pradhan RK, Qi F, Beard DA, Dash RK. Characterization of membrane potential dependency of mitochondrial Ca2+ uptake by an improved biophysical model of mitochondrial Ca2+ uniporter. PLoS One. 2010;5(10):e13278. doi: 10.1371/journal.pone.0013278. [PMC free article] [PubMed] [Cross Ref]

Articles from BMC Biochemistry are provided here courtesy of **BioMed Central**

PubMed Central Canada is a service of the Canadian Institutes of Health Research (CIHR) working in partnership with the National Research Council's national science library in cooperation with the National Center for Biotechnology Information at the U.S. National Library of Medicine(NCBI/NLM). It includes content provided to the PubMed Central International archive by participating publishers. |